Journals in Pharmaceutical analysis

Acta Pharmaceutica Sinica B

ISSN: 2211-3835
5 Year impact factor: 14.1
Impact factor: 14.7

The Journal of the Institute of Materia Medica, the Chinese Academy of Medical Sciences and the Chinese Pharmaceutical Association Peer Review under the responsibility of Institute of Materia Medica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical AssociationActa Pharmaceutica Sinica B (APSB) is a monthly journal, in English, which publishes significant original research articles, rapid communications and high quality reviews of recent advances in all areas of pharmaceutical sciences including pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis and pharmacokinetics.APSB is a series of journal of Acta Pharmaceutica Sinica, which was founded in 1953, indexed in Chemical Abstracts, Index Medicus, SciFinder Scholar, Biological Abstracts, International Pharmaceutical Abstracts, Cambridge Scientific Abstracts, Current Bibliography on Science and Technology, etc. It sponsored by Insititute of Materia Medica, Chineses Acedemy of Medical Sciences and Chinese Pharmaceutical Association, production and hosting by Elsevier B.V.

Heliyon

ISSN: 2405-8440
5 Year impact factor: 3.9
Impact factor: 3.4

Heliyon considers research from all areas of the physical, applied, life, social and medical sciences. We publish manuscripts reporting scientifically accurate and valuable research, which adheres to accepted ethical and scientific publishing standards. As such Heliyon publishes new insights as well as extensions on existing theories, negative/null results and replication studies.Submissions covering arts, humanities and law are not considered in Heliyon. Authors of these submissions are encouraged to submit directly to our partner journal Social Sciences & Humanities Open.Heliyon classifies manuscripts/articles into different sections based on the research topic discussed. Some sections exclude certain types of studies from their scope. To know more and to see the kind of manuscripts the various sections publish, please visit: https://www.cell.com/heliyon/sectionsA dedicated in-house editorial office team, internal editors as well as external academic section and associate editors handle your manuscript and manage the publication process, giving your research the editorial support and quality control it deserves.If it's important to you, it's important to us. Submit your paper today.

Journal of Pharmaceutical Analysis

ISSN: 2095-1779
5 Year impact factor: 6.8
Impact factor: 6.1

The journal of the Xi'an Jiaotong UniversityJournal of Pharmaceutical Analysis (JPA), launched in 2011, is an official journal of Xi'an Jiaotong University.JPA is a monthly peer-reviewed open access journal that publishes significant Original research articles, Review papers, Short communications, News, Research highlight, and Editorial in the field of Analysis of Pharmacy, broadly covering Pharmaceutical analysis, Analytical techniques and methods, Pharmacology, Metabolism, Drug delivery, Cellular imaging & analysis, Natural products and Biosensing.Other analytical areas that JPA is interested in are: Biology, Nanotechnology, Pharmacognosy, Medicinal chemistry, Clinical laboratory analysis and Artificial intelligence.JPA has a distinguished editorial board with extensive academic qualifications, ensuring that every issue of the journal contains cutting-edge articles on the developments in the field of Analysis of Pharmacy.

Journal of Pharmaceutical and Biomedical Analysis

ISSN: 0731-7085
5 Year impact factor: 3.1
Impact factor: 3.1

This journal is an international medium directed towards the needs of academic, clinical, government and industrial analysis by publishing original research reports and critical reviews on pharmaceutical and biomedical analysis. It covers the interdisciplinary aspects of analysis in the pharmaceutical, biomedical and clinical sciences, including developments in analytical methodology, instrumentation, computation and interpretation. Submissions on novel applications focusing on drug purity and stability studies, pharmacokinetics, therapeutic monitoring, metabolic profiling; drug-related aspects of analytical biochemistry and forensic toxicology; quality assurance in the pharmaceutical industry are also welcome.Studies from areas of well established and poorly selective methods, such as UV-VIS spectrophotometry (including derivative and multi-wavelength measurements), basic electroanalytical (potentiometric, polarographic and voltammetric) methods, fluorimetry, flow-injection analysis, etc. are accepted for publication in exceptional cases only, if a unique and substantial advantage over presently known systems is demonstrated. The same applies to the assay of simple drug formulations by any kind of methods and the determination of drugs in biological samples based merely on spiked samples. Drug purity/stability studies should contain information on the structure elucidation of the impurities/degradants.Papers dealing with the analytical aspects of traditional folk medicines are acceptable if the results are expected to attract the interest of readers also outside the area of origin, i.e. they have a focus on innovative analytical approaches. Regional differences in the phytochemical content of traditional folk medicine will not be considered. Manuscripts reporting on the analysis of novel phytochemicals will only be considered if their biological activity has been previously published in an international medium. Pharmacokinetic studies of traditional folk medicine will only be considered if only the identified components have been demonstrated to be solely responsible for the pharmacological activity.Bioanalytical papers (pharmacokinetic, bioequivalence, protein and DNA binding studies) are accepted if the focus is on innovative analytical methodology. Manuscripts describing the pharmacokinetic profile of a single compound will not be considered for review. Pharmacokinetic studies will only be considered if they offer new profiles of a drug(s) and its metabolite(s) or new understandings of the mechanisms in drug disposition or response of existing drugs. Analytical studies on new investigational drugs that are currently in the preclinical phase are only acceptable if their pharmacological activity is well documented in an international medium.Human subjects research must provide ethical approval and should include the name of the approving committee and the name of the institution and reference number where approval was granted. Animal studies must be approved from their Institutions Animal Care and Use Committee or any equivalent ethics committee accompanied by the reference number. For blood sampling procedures in rodents, retro-orbital bleeding will only be considered if a minimum of 7 days is allowed between repeat sampling. Furthermore, in the evaluation of the manuscript the editors reserve the right to determine whether the animal experimental technique is appropriate.In determining the suitability of submitted articles for publication, particular scrutiny will be placed on the degree of novelty and significance of the research and the extent to which it adds to existing knowledge in pharmaceutical and biomedical analysis. In all submissions to the journal, authors must address the question of how their proposed methodology compares with previously reported methods. A substantial body of work cannot be fractionated into different shorter papers.

Saudi Pharmaceutical Journal

ISSN: 1319-0164
5 Year impact factor: 3.9
Impact factor: 3

Peer Review under the responsibility of King Saud UniversityThe Saudi Pharmaceutical Journal (SPJ) is the official journal of the Saudi Pharmaceutical Society (SPS) publishing high quality clinically oriented submissions which encompass the various disciplines of pharmaceutical sciences and related subjects. SPJ publishes 8 issues per year by the Saudi Pharmaceutical Society, with the cooperation of the College of Pharmacy, King Saud University.All articles published in Saudi Pharmaceutical Journal have undergone a full peer review and are:Scientifically soundIn compliance with international research and publishing ethicsWritten in clear, concise and correct EnglishA valid, contribution to the existing literature and of educational value to the specific community and readersNot previously published materialThe journal publishes full-length articles, short reviews (not exceeding 12 pages which are intended to debate the recent advances in rapidly developing fields), short communications, case studies, letters to the editor and book reviews.Readership Medicinal chemists, Pharmacologists, Pharmacists, Toxicologists, Clinicians and all other health practitioners.Keywords Medicinal chemistry, structure based drug design, drug target, industrial pharmacy, medicinal research, drug targeting, enzyme inhibitors, receptor, pharmaceutical chemistry, drug delivery, drug discovery, biological chemistry, drug development, pharmaceutical technology, and pharmaceutical biotechnology.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: https://service.elsevier.com Accredited as a refereed Journal by the Scientific Council of King Saud University, Riyadh, Kingdom of Saudi Arabia.

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health